Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) was the recipient of a large drop in short interest in May. As of May 15th, there was short interest totalling 923,300 shares, a drop of 12.1% from the April 30th total of 1,050,000 shares. Currently, 2.6% of the company’s shares are sold short. Based on an […]
Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) was the target of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 923,300 shares, a drop of 12.1% from the April 30th total of 1,050,000 shares. Based on an average daily trading volume, of 309,500 […]
Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) was the target of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 923,300 shares, a decrease of 12.1% from the April 30th total of 1,050,000 shares. Based on an average daily volume of 309,500 shares, […]
JMP Securities reaffirmed their market outperform rating on shares of Athira Pharma (NASDAQ:ATHA – Free Report) in a research note released on Thursday morning, Benzinga reports. JMP Securities currently has a $19.00 price objective on the stock. Athira Pharma Price Performance Shares of ATHA stock opened at $2.52 on Thursday. Athira Pharma has a 1 […]
Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) saw a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 717,600 shares, an increase of 39.6% from the January 15th total of 513,900 shares. Based on an average daily volume of 331,300 shares, the short-interest ratio […]